CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 7. Radicicol inhibits SRF and AP-1 activity. ras-transformed cells were treated with 0.5 µM radicicol for 36–40 h and reporter activities were analyzed by a dual-luciferase reporter assay as described in "Materials and Methods." Reporter activity in radicicol-treated cells is expressed as the percentage of that in untreated cells. Shown is the average ± SD of quadruplicates from a representative experiment of three performed. pMCS-luc, a reporter construct without enhancer elements.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation